Complex heart surgery on a two-day old at NH, Jaipur

Gunjan Chauhan
Gunjan Chauhan
· 4 min read
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage

Super Specialists in the cardiac sciences department at Narayana Multispeciality Hospital, Jaipur successfully diagnosed and treated a ‘two day’ old newborn born with Coarctation of Aorta (CoA). CoA is a critical cardiac defect in which a portion of the aorta (main blood vessel supplying oxygen rich blood to the body) is very narrow, and blocks blood flow to the lower half of the body. In this case, the aorta was severely constricted, needing immediate corrective surgery otherwise the newborn would not have survived.

The congenital anomaly came to light when the newborn’s mother underwent a routine foetal echo during her pregnancy. Results of the echo suspected Coarctation of Aorta (CoA) in the foetus (unborn child). Being a high-risk pregnancy, the parents were counselled to plan delivery of the baby at a tertiary center having a full-fledged cardiac program as well as having capability to manage high risk pregnancy. It was important that the hospital should have neonatal cardiac surgeons, neonatologists, pediatric cardiologists, gynecologists and cardiac anesthetists & intensivists. The parents-to-be came to Narayana Multispeciality Hospital, Jaipur where under the close monitoring of Dr. Richa Choudhary, Consultant – Obstetrics & Gynecology & actively supported by a team of multi-disciplinary experts, the delivery was successful.

 The newborn weighing 2.7 kgs was kept under close observation in the hospital’s Neonatal ICU, and an ECHO was done within 24 hours of birth to check all vitals. The ECHO diagnosed and confirmed Co-arctation of Aorta with associated PDA.  The narrowing of the Aorta was blocking blood flow to the lower half of the body resulting in deficient blood supply to vital organs such as liver, kidneys etc.

At birth, the lower half of the body also gets blood through an additional source known as ductus arteriosus, which naturally closes within a few minutes after birth. Under the guidance of Dr. Prashant Mahawar, Consultant – Pediatric Cardiology, special drugs were administered which helped keep the ductus arteriosus open to maintain the blood supply, which is a mandatory step to keep the newborn alive until surgery is performed. Within 48 hours post-delivery, a team of doctors headed by Dr. CP Srivastava, HOD & Chief Consultant – Cardiac Surgery and Dr. Pradeep Goyal, HOD & Sr. Consultant – Anesthesia & Critical Care operated upon the newborn. The narrowed portion of the aorta was surgically removed, and the aorta was re-constructed to allow blood to flow normally through it.

Incidentally, the mother had undergone corrective heart surgery for Tetralogy of Fallot, 14 years back by Dr. CP Srivastava when he was in SMS Hospital, Jaipur.

Operating newborns with congenital heart defects is challenging as the size of a baby’s heart is very small and there are risks involved like internal bleeding during or post-surgery, breathing problems etc. Post-operative management of a newborn is also very critical since all the organs, especially lungs, are in the initial developing stage and require skilled critical care doctors for management” said Dr. CP Srivastava. Commenting on the complexity of the surgery Dr. Pradeep Goyal said The real challenge was the age and size of the newborn wherein any intervention would require manipulation in very tiny vessels”

Commenting on the surgery Mr. Karthik Ramakrishnan, Facility Director at Narayana Multispeciality Hospital, Jaipur said, “While Narayana Multispecialty Hospital performs more than 40 pediatric cardiac surgeries in a month, successfully operating on a two-day old neonate requires special expertise and skills and is made possible only by our extensive experience in operating on high risk cardiac patients. Our infrastructure & team is well equipped to handle such high-risk cases and we are happy we could make a difference to the baby and the parents.”

With all super-speciality tertiary care facilities that the medical world offers, Narayana Health is a one-stop healthcare destination for all. Founded by Dr. Devi Shetty and headquartered in Bengaluru, Narayana Health group is the second largest health care provider in the country in terms of operational bed count. The first facility was established with approximately 225 operational beds in year 2000 at NH Health City in Bengaluru.  The Company today operates a chain of multispecialty tertiary and primary healthcare facilities across a network of 24 hospitals and 7 heart centres in India and single hospital overseas at Cayman Islands with nearly 6,000 operational beds across all its centres and potential to reach a capacity of over 7,000 beds 

Read Next

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  
News
May 19, 2026

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  

Zydus Wellness Limited reported a consolidated growth of 62.1% in Net Sales, which stood at Rs. 14,761 million as compared to Rs. 9,106 million in the corresponding period of the previous year. The Company reported annual Net Sales of Rs. 39,400 million, with a y-o-y growth of 46.4% in FY 26. EBITDA for the period […]
Article by: IMT News Desk
Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%
News
May 19, 2026

Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%

Strides Pharma Science Ltd. reported a robust FY26 performance, with consolidated EBITDA rising to ₹9,253 crore and operational profit after tax (PAT) at ₹5,181 crore, up 50.3% year‑on‑year. The company’s ex‑US markets outpaced the rest of the business, posting 21% YoY revenue growth, while disciplined execution expanded full‑year EBITDA margin to 19%, up 140 basis points from FY25. […]
Article by: IMT News Desk
Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk